Skip to main content

Clitoral Phimosis and Clitoral Adhesions

Clitoral phimosis is the inability to retract the clitoral prepuce (clitoral hood) to expose the entire glans clitoris. It is a distinct entity from clitoral adhesions, in which the prepuce is directly tethered to the glans by epithelial bridging. Either may be asymptomatic or associated with trapped keratin / smegma, periclitoral pseudocysts or pain. Sexual symptoms require a broader assessment; phimosis alone does not establish the cause of impaired arousal or orgasm. Scarring may be an architectural sequela of vulvar lichen sclerosus (LS).[1][2][3]

For the underlying dermatologic disease, see Lichen Sclerosus. For aesthetic clitoral-hood reduction in the absence of pathologic phimosis, see Inverted-Y Clitoral Hoodoplasty and Liu Classification Hoodoplasty — those are cosmetic procedures and are not interchangeable with phimosis release.

Definition and Classification​

A 2025 international Delphi consensus (Krapf et al.) standardized terminology:[1]

  • Clitoral phimosis — inability to retract the prepuce to expose the entire glans clitoris.
  • Clitoral adhesions — direct tethering of the prepuce to the glans clitoris.
  • The degree of phimosis should be classified as mild, moderate, or severe, and described as partially retractable or completely non-retractable.
  • Both prepuce characteristics and glans size should be documented.

The two entities frequently coexist (phimotic prepuce with bridging adhesions to the glans beneath) and treatment depends on symptoms and underlying disease. Selected symptomatic adhesions may be lysed in the office; persistent symptomatic scar-related phimosis may warrant specialist surgical release.[1][4]

Prevalence​

PopulationRate
3,650 sexually active women (general cohort)1.3% had any form of clitoral phimosis; severe in 9 cases[5]
Sexual-dysfunction clinic referrals22% in the cited referral cohort; not a population prevalence[2]

Etiology​

CauseNotes
Lichen sclerosus (LS)An important scarring cause — chronic inflammation, epithelial thinning, and progressive scarring fuse the labia minora, phimose the clitoral hood, and create the classic "figure of eight" architectural distortion of the vulva.[3][6]
Lichen planus (LP)Similar scarring mechanism with mucosal involvement[7]
Recurrent vulvar dermal infections / blunt traumaAlters preputial elasticity over time[2]
Congenital fusionRare; can present as a periclitoral mass from trapped sebaceous material[8]
Anatomic predispositionThe glandopreputial sulcus of the clitoris is often incompletely formed (unlike the penile sulcus), predisposing to phimosis, cyst formation, and pilonidal sinus[9]

Clinical Presentation​

  • Sexual dysfunction — decreased clitoral sensation, impaired arousal, anorgasmia, and dyspareunia. Most consistent in severe LS-related phimosis.[5][10]
  • Sexual pain — the symptom most reliably associated with phimosis on regression analysis.[2]
  • Smegma / keratin pearl accumulation beneath the fused prepuce — palpable mass that can mimic vulvar malignancy.[8][11]
  • Pseudocyst formation from trapped eccrine secretions.[9]
  • Pediatric / adolescent LS — phimosis presents alongside labial resorption and adhesion formation; can cause urinary retention or significant pain.[12]

Diagnosis​

  • Exam-based. Cephalad displacement of the labia minora to retract the prepuce. Inability to fully expose the glans confirms the diagnosis.[2]
  • Document phimosis vs adhesion — phimosis is preputial-aperture stenosis; adhesions are epithelial bridges that may be lysed at the bedside.[1]
  • Biopsy when the diagnosis is uncertain, treatment fails or a lesion is suspicious for neoplasia; persistent focal hyperkeratosis, ulceration or a mass warrants assessment. LS-associated cancer risk supports surveillance, not routine biopsy of every clitoral adhesion.[6]
  • The clitoris should be routinely examined in any patient presenting with sexual dysfunction, vulvar symptoms, or known vulvar dermatoses.[4]

Treatment Ladder​

Treatment is guided by severity, symptom burden, and underlying etiology; asymptomatic adhesions do not automatically require intervention. BAD guidance supports treatment of inflammation and selective surgery for troublesome scarring.[14] Most patients require ongoing dermatologic maintenance even after a successful procedure because the underlying LS / LP is chronic.[7][10]

1. Medical (first-line for the underlying dermatosis)​

  • High-potency topical corticosteroids — an individualized induction and maintenance regimen (see the linked LS page). Prevents progression but does not reverse established architectural changes.[3][6][12]
  • Maintenance therapy is essential to prevent recurrence and reagglutination after any procedure.[7][3]

2. Office lysis of symptomatic adhesions​

For selected symptomatic clitoral adhesions, after consent and adequate analgesia, office-based lysis with fine Jacobsen mosquito forceps to separate prepuce from glans, with removal of trapped smegma and keratin pearls. In the Myers 2022 retrospective series, 41 of 61 eligible patients responded (67%); the following are respondent-reported outcomes without a control group or validated pre/post instrument:[4]

  • 76% reported pain improvement
  • 63% improved arousal
  • 64% improved orgasmic function
  • 93% would recommend the procedure

Fixed scar-related preputial narrowing needs a separate specialist assessment; neither finding by itself mandates a procedure.

3. Surgical management (persistent symptomatic phimosis)​

Clitoral circumcision / prepucectomy​

Excision of the phimotic preputial ring to expose the glans clitoris. Small uncontrolled reports include Goldstein / Burrows and the Chmel study (9 women with severe phimosis); these do not establish comparative superiority:[10][5]

  • FSFI improved from 17.9 → 26.6 at 12 months (p < 0.001)
  • Significant improvement in arousal, orgasm, and dyspareunia domains
  • Concurrent perineoplasty may be required when introital stenosis coexists.[5]

CO₂ laser preputial release​

Used for clitoral phimosis secondary to LS or LP with individualized pre- and postoperative topical therapy. Kroft / Shier series of 23 women:[7]

  • Some reagglutination occurred (5/20 LS patients).
  • 5 patients required reoperation.
  • Overall satisfaction was high.

Surgicel application after lysis​

Oxidized regenerated cellulose (Surgicel) applied to exposed surfaces after surgical lysis of adhesions to prevent reagglutination — Breech 2000 small adolescent series with no recurrence at 1 year.[11]

Postoperative Considerations​

  • Reagglutination is the dominant failure mode — reported in ~25% of LS patients after CO₂ laser.[7]
  • Continued topical-steroid maintenance is critical — the underlying dermatosis drives recurrence.[10][7]
  • Periodic surveillance examination for both reagglutination and for the lifelong vulvar SCC risk in LS patients.[6]

Key Principles​

  • Clitoral phimosis is distinct from clitoral adhesions — the Krapf 2025 Delphi consensus standardized this distinction.[1]
  • LS is an important cause; treat the underlying dermatosis with maintenance topical steroids regardless of whether a procedure is offered.[3][6]
  • Symptomatic adhesions may be treated with office lysis; persistent symptomatic scar-related phimosis may require surgical release after control of inflammation.[4][1]
  • Aesthetic clitoral hoodoplasty is not interchangeable with phimosis release — different anatomy, different goals, different outcome instruments.[13]
  • Reagglutination (~25% with CO₂ laser in LS) drives the need for ongoing topical-steroid maintenance.[7]
  • Biopsy suspicious lesions in any LS patient; continue surveillance for LS-associated vulvar SCC.[6]
  • Pediatric LS demands early diagnosis — ~50% of children present with already irreversible atrophic changes from diagnostic delay (median 7 months).[12]
  • Offer a consented clitoral examination when assessing relevant sexual symptoms or vulvar disease. Referral-cohort prevalence does not prove that every sexual symptom arises from phimosis.[5][2]

See Also​

References​

1. Krapf JM, Pope R, Rubin RS, Moss CF, Mauskar MM. Definition and classification of clitoral phimosis and adhesions: an international Delphi study. BJOG. 2025. doi:10.1111/1471-0528.70066.

2. Munarriz R, Talakoub L, Kuohung W, et al. The prevalence of phimosis of the clitoris in women presenting to the sexual dysfunction clinic: lack of correlation to disorders of desire, arousal and orgasm. J Sex Marital Ther. 2002;28 Suppl 1:181-5. doi:10.1080/00926230252851302.

3. Ringel NE, Iglesia C. Common benign chronic vulvar disorders. Am Fam Physician. 2020;102(9):550-557.

4. Myers MC, Romanello JP, Nico E, et al. A retrospective case series on patient satisfaction and efficacy of non-surgical lysis of clitoral adhesions. J Sex Med. 2022;19(9):1412-1420. doi:10.1016/j.jsxm.2022.06.011.

5. Chmel R, Nováčková M, Fait T, et al. Clitoral phimosis: effects on female sexual function and surgical treatment outcomes. J Sex Med. 2019;16(2):257-266. doi:10.1016/j.jsxm.2018.12.012.

6. Committee on Practice Bulletins–Gynecology. Diagnosis and management of vulvar skin disorders: ACOG Practice Bulletin, Number 224. Obstet Gynecol. 2020;136(1):e1-e14. doi:10.1097/AOG.0000000000003944.

7. Kroft J, Shier M. A novel approach to the surgical management of clitoral phimosis. J Obstet Gynaecol Can. 2012;34(5):465-471. doi:10.1016/S1701-2163(16)35243-4.

8. Maybury EK, Recio FO, Ahmad S, McKenzie ND. Fused clitoral hood presenting as a periclitoral mass. Obstet Gynecol. 2022;140(6):1056-1060. doi:10.1097/AOG.0000000000004996.

9. van der Putte SC, Sie-Go DM. Development and structure of the glandopreputial sulcus of the human clitoris with a special reference to glandopreputial glands. Anat Rec (Hoboken). 2011;294(1):156-64. doi:10.1002/ar.21279.

10. Goldstein AT, Burrows LJ. Surgical treatment of clitoral phimosis caused by lichen sclerosus. Am J Obstet Gynecol. 2007;196(2):126.e1-4. doi:10.1016/j.ajog.2006.08.023.

11. Breech LL, Laufer MR. Surgicel in the management of labial and clitoral hood adhesions in adolescents with lichen sclerosus. J Pediatr Adolesc Gynecol. 2000;13(1):21-2. doi:10.1016/s1083-3188(99)00029-7.

12. Nerantzoulis I, Grigoriadis T, Michala L. Genital lichen sclerosus in childhood and adolescence — a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae. Eur J Pediatr. 2017;176(10):1429-1432. doi:10.1007/s00431-017-3004-y.

13. American College of Obstetricians and Gynecologists. Elective female genital cosmetic surgery: ACOG Committee Opinion, Number 795. Obstet Gynecol. 2020;135(1):e36-e42. doi:10.1097/AOG.0000000000003616.

14. Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018;178:839–853. doi:10.1111/bjd.16241.